Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2600115969) titled 'Efficacy and safety of doxorubicin liposomal and adebrelimab in the treatment of osteosarcoma failed standard treatment: a multicenter, interventional clinical study' on Jan. 4.
Study Type: Interventional study
Study Design:
Historical control
Primary Sponsor: Shanghai Sixth People's Hospital
Condition:
Osteosarcoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-07
Target Sample Size: Experimental group:67;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=297688
Published by HT Digital Content Services with permission...